Chang Yi Wang, Ph.D.
Co-founder of UBI, Chairperson of the Board of Directors since 1998, and Chairperson and CEO of UBI-Asia. Dr. Wang is the principal inventor of over 80 of UBI’s issued patents and patent applications. Under her direction, the UBITh platform technology was developed. She has published more than 120 peer reviewed scientific papers and has been invited to give plenary lectures in the areas of immunology, vaccination, immunotherapeutics and infectious diseases. She also serves on the US NIH scientific review committee for the “Cooperative Research Partnerships for BioDefense” funding program and the SBIR Immunobiology and Allergy funding program. In 2007 Dr. Wang received the Inventor of the Year Award from the New York Intellectual Property Law Association (NYPLA). From 1981 to 1985, Dr. Wang was a principal investigator and head of the Laboratory of Molecular Immunology at the Memorial Sloan-Kettering Cancer Center in New York and a faculty member of the Department of Immunology, Sloan-Kettering Division, Cornell University Medical School. Dr. Wang received her B.S. degree in Chemistry from National Taiwan University and her Ph.D. degree in Immunology and Biochemistry from The Rockefeller University, New York.
Mei Mei Hu, J.D.,
Former consultant at McKinsey & Co. in the New York office where she advised leading pharmaceutical companies on strategic, operational and management issues. Prior to that, Ms. Hu was an associate at Cravath, Swaine and Moore in the Securities group. She graduated magna cum laude from University of Pennsylvania, in Economics, received a JD from Harvard Law School, and General Course from London School of Economics.
Louis G. Reese IV,
Has over 10 year’s experience as an entrepreneur and investor, specializing in identifying growth opportunities, sourcing financing and structuring deals. He is a cofounder and partner at Jack Green Group, and has active investments in real estate, oil and gas, medical devices, consumer goods, and renewable energy. He attended Columbia Business School and University of Pennsylvania.
Member of the Board of Directors since 1999, filling the position held for the previous 6½ years by Dr. James Watson, the Nobel laureate and co-discoverer of the structure for DNA, who retired from the Board at age 70. Currently, Mr. Sistemans is the Chairman of the Advisory Council for Science and Technology Policy to the Prime Minister, the Netherlands. He serves on the boards of numerous private and public organizations in the Netherlands. He has been a Supervisory Board Member of the University in Enschede the Netherlandss and the Maastricht School of Management. He was the CEO of Origin B.V., an information technology company in the Netherlands from 1999 to 2001. From 1994 to 1999, Mr. Sistermans served as the Executive Vice President of Akzo Nobel responsible for Strategy and Technology.
Flossie Wong-Staal, Ph.D. Director
Dr. Wong-Staal is a Professor of Medicine and Biology and has held the Florence Riford Chair in AIDS Research at the University of California, San Diego (UCSD) since 1990. Dr. Wong-Staal is an internationally recognized leader in virology and one of the pioneers of AIDS research. While at the National Cancer Institute (NCI), she and her colleagues were the first to decipher the complex structure of HIV, Dr. Wong-Staal serves on the National Task Force on AIDS Drug Development, the Health Policy Board of the Institute of Medicine, the Science Board for the Food and Drug Administration and the Board of Scientific Counselors for the National Institute of Allergy and Infectious Diseases. She has been elected as a member of the Institute of Medicine, the Academia Sinica, and as an honorary member of the American Society of Clinical Investigation. In 2002, Discover Magazine named Dr. Wong-Staal one of the fifty most extraordinary women scientists.